Medical Marijuana Sales General Limitations – M403 Proposed Rule Change.
Cannabis Regulatory Solutions wants all of our clients to know that the MED has proposed (1) broadening the definition of “Medical Marijuana” to specifically include Medical Marijuana Concentrate (see definitions) and (2) removing the confusing statement in regard to “medical marijuana equivalents” contained within the existing Rule M403.
If adopted, the proposed changes would provide clarity that Medical Marijuana Centers are limited to selling up to two ounces of medical marijuana (including medical marijuana concentrate) during a single sales transaction UNLESS the patient has designated the center as his/her primary center AND supplied documentation from the patient’s physician allowing more than two ounces.
The M403 proposed rule change should be viewed as very good news. They fulfill the ongoing needs of seriously ill medical marijuana patients while clarifying what has been very a confusing and misunderstood issue. Additional changes have been written into M403. Readers are encouraged to review them.
The proposed rules are to be heard on October 16, 2017. They are published on the MED’s website at:
- Proposed Medical Marijuana Rules
- Proposed Retail Marijuana Rules
- MED 2016 Rulemaking Page
- MED Rule Comment Form
Written comments on proposed rules will be accepted until 5:00 PM on October 16, 2017. The date, time, and location of the public rulemaking hearing is as follows
For additional rules impacting the marijuana industry, please visit our Law Page by clicking here.